BR112014027991A2 - agentes para neutralização de influenza - Google Patents
agentes para neutralização de influenzaInfo
- Publication number
- BR112014027991A2 BR112014027991A2 BR112014027991A BR112014027991A BR112014027991A2 BR 112014027991 A2 BR112014027991 A2 BR 112014027991A2 BR 112014027991 A BR112014027991 A BR 112014027991A BR 112014027991 A BR112014027991 A BR 112014027991A BR 112014027991 A2 BR112014027991 A2 BR 112014027991A2
- Authority
- BR
- Brazil
- Prior art keywords
- agents
- antibodies
- influenza
- neutralizing influenza
- neutralizing
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title abstract 4
- 230000003472 neutralizing effect Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
resumo patente de invenção: "agentes para neutralização de influenza". a presente invenção refere-se a anticorpos (por exemplo, anticorpos monoclonais, anticorpos de humano, anticorpos humanizados, etc.), que se ligam a múltiplas cepas de influenza. tais anticorpos são úteis, por exemplo, em profilaxia, tratamento, diagnóstico e/ou estudo de influenza.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261645453P | 2012-05-10 | 2012-05-10 | |
PCT/US2013/031704 WO2013169377A1 (en) | 2012-05-10 | 2013-03-14 | Agents for influenza neutralization |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014027991A2 true BR112014027991A2 (pt) | 2017-07-18 |
Family
ID=49548780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014027991A BR112014027991A2 (pt) | 2012-05-10 | 2013-03-14 | agentes para neutralização de influenza |
Country Status (14)
Country | Link |
---|---|
US (4) | US9683030B2 (pt) |
EP (2) | EP3492101A3 (pt) |
JP (2) | JP6431477B2 (pt) |
KR (1) | KR102122618B1 (pt) |
CN (2) | CN104507500A (pt) |
AU (2) | AU2013260123A1 (pt) |
BR (1) | BR112014027991A2 (pt) |
CA (1) | CA2871160C (pt) |
CL (1) | CL2014003052A1 (pt) |
HK (1) | HK1207970A1 (pt) |
IL (1) | IL235237A0 (pt) |
MX (1) | MX2014013678A (pt) |
SG (2) | SG10201807059QA (pt) |
WO (1) | WO2013169377A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
EP3492101A3 (en) | 2012-05-10 | 2019-10-23 | Massachusetts Institute Of Technology | Agents for influenza neutralization |
TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
MY186585A (en) | 2015-02-05 | 2021-07-28 | Janssen Vaccines & Prevention Bv | Binding molecules directed against influenza hemagglutinin and uses thereof |
JP6921002B2 (ja) * | 2015-05-11 | 2021-08-18 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | ペプチド模倣化合物を中和するインフルエンザウイルス |
WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
CN109195629A (zh) | 2016-02-24 | 2019-01-11 | 威特拉公司 | 流行性感冒抗体分子制剂 |
KR101887876B1 (ko) | 2016-08-18 | 2018-08-13 | 한국과학기술연구원 | H5형 조류독감 바이러스에 특이적으로 결합하는 핵산 압타머 및 이를 이용하는 h5형 조류독감 바이러스의 검출방법 |
CN113924147A (zh) | 2019-03-25 | 2022-01-11 | 威特拉公司 | 用于治疗和预防流感的组合物和方法 |
EP4073107A1 (en) | 2019-12-11 | 2022-10-19 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL23522C (pt) | 1927-03-23 | |||
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US4938948A (en) | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
SG46445A1 (en) | 1990-01-26 | 1998-02-20 | Immunomedics Inc | Vaccines against cancer and infectious diseases |
JPH049249A (ja) | 1990-04-27 | 1992-01-14 | Kusuda:Kk | 塗型剤吹き付け機 |
US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
JPH06247995A (ja) | 1991-06-24 | 1994-09-06 | Asahi Chem Ind Co Ltd | 新規なシアリル(α2−6)ラクトテトラオシルセラミド |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
ES2146648T3 (es) | 1993-03-09 | 2000-08-16 | Genzyme Corp | Procedimiento de aislamiento de proteinas de la leche. |
US5500161A (en) | 1993-09-21 | 1996-03-19 | Massachusetts Institute Of Technology And Virus Research Institute | Method for making hydrophobic polymeric microparticles |
US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
JP3584990B2 (ja) * | 1994-05-09 | 2004-11-04 | タカラバイオ株式会社 | 抗ヒトインフルエンザウイルス抗体 |
US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
DE19643314A1 (de) * | 1996-10-21 | 1998-04-23 | Boehringer Mannheim Gmbh | Monoklonale Antikörper gegen das Epitop YPYDVPDYA, Verfahren zu deren Herstellung und Verwendung |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
EP1167382A1 (en) | 1999-03-31 | 2002-01-02 | Otsuka Pharmaceutical Co., Ltd. | Influenza virus hemagglutinin-binding peptides |
DK2322631T3 (en) | 2001-04-19 | 2015-01-12 | Scripps Research Inst | Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar |
US7118915B2 (en) | 2001-09-27 | 2006-10-10 | Pieris Proteolab Ag | Muteins of apolipoprotein D |
WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
WO2003074570A1 (fr) | 2002-03-04 | 2003-09-12 | Japan Science And Technology Agency | Nouvelles molecules de sialo-sucre ramifiees et agents antiviraux les utilisant |
CA2492671C (en) | 2002-03-22 | 2012-04-17 | Aprogen, Inc. | Humanized antibody and process for preparing same |
EP1573047B1 (en) | 2002-08-20 | 2013-11-13 | OpSaniTx LLC | Lectin compositions and methods for modulating an immune response to an antigen |
EP2272950A3 (en) | 2004-11-11 | 2011-07-20 | Abbott Biologicals B.V. | Defective influenza virus particles |
WO2006056464A2 (en) | 2004-11-26 | 2006-06-01 | Pieris Ag | Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) |
NZ555308A (en) | 2004-12-22 | 2010-10-29 | Ambrx Inc | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
CN101501696A (zh) | 2006-08-14 | 2009-08-05 | 麻省理工学院 | 聚糖数据挖掘系统 |
US20090081193A1 (en) | 2006-08-14 | 2009-03-26 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
US20100061990A1 (en) | 2006-08-14 | 2010-03-11 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
US20090269342A1 (en) | 2006-08-14 | 2009-10-29 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
KR101719135B1 (ko) | 2007-06-25 | 2017-03-23 | 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 | 인플루엔자를 억제하는 조성물 및 방법 |
FR2921928B1 (fr) * | 2007-10-08 | 2011-03-04 | Sanofi Pasteur | Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal |
EP3524619A1 (en) * | 2007-12-06 | 2019-08-14 | Dana-Farber Cancer Institute, Inc. | Antibodies against influenza virus and methods of use thereof |
WO2009089121A2 (en) | 2008-01-03 | 2009-07-16 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
DK2257624T5 (da) | 2008-02-05 | 2012-09-10 | Medical Res Council | Fremgangsmåder og sammensætninger |
CA2731686C (en) | 2008-07-25 | 2020-04-07 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
US8871207B2 (en) * | 2008-07-25 | 2014-10-28 | Humabs, LLC | Neutralizing anti-influenza A virus antibodies and uses thereof |
CA2787940C (en) | 2010-01-27 | 2020-01-07 | Massachusetts Institute Of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
JP2013531474A (ja) * | 2010-04-30 | 2013-08-08 | エスペランス ファーマシューティカルズ, インコーポレイテッド | 溶解性ペプチド−Her2/neu(ヒト上皮成長因子レセプター2)リガンド結合体およびその使用方法 |
BR112013007946B1 (pt) * | 2010-10-04 | 2022-07-12 | Massachusetts Institute Of Technology | Composições farmacêuticas e imunogênicas compreendendo polipeptídeos de hemaglutinina |
EP3492101A3 (en) | 2012-05-10 | 2019-10-23 | Massachusetts Institute Of Technology | Agents for influenza neutralization |
JP6247995B2 (ja) | 2014-04-22 | 2017-12-13 | 東京エレクトロン株式会社 | 接合方法、プログラム、コンピュータ記憶媒体、接合装置及び接合システム |
-
2013
- 2013-03-14 EP EP18196965.0A patent/EP3492101A3/en not_active Withdrawn
- 2013-03-14 EP EP13787149.7A patent/EP2846833A4/en not_active Withdrawn
- 2013-03-14 SG SG10201807059QA patent/SG10201807059QA/en unknown
- 2013-03-14 CN CN201380024604.3A patent/CN104507500A/zh active Pending
- 2013-03-14 CN CN201811019451.4A patent/CN109265541A/zh active Pending
- 2013-03-14 US US13/829,675 patent/US9683030B2/en active Active
- 2013-03-14 JP JP2015511463A patent/JP6431477B2/ja active Active
- 2013-03-14 BR BR112014027991A patent/BR112014027991A2/pt not_active Application Discontinuation
- 2013-03-14 CA CA2871160A patent/CA2871160C/en active Active
- 2013-03-14 AU AU2013260123A patent/AU2013260123A1/en not_active Abandoned
- 2013-03-14 WO PCT/US2013/031704 patent/WO2013169377A1/en active Application Filing
- 2013-03-14 MX MX2014013678A patent/MX2014013678A/es unknown
- 2013-03-14 SG SG11201406769RA patent/SG11201406769RA/en unknown
- 2013-03-14 KR KR1020147034586A patent/KR102122618B1/ko active IP Right Grant
-
2014
- 2014-10-21 IL IL235237A patent/IL235237A0/en active IP Right Grant
- 2014-11-10 CL CL2014003052A patent/CL2014003052A1/es unknown
-
2015
- 2015-09-02 HK HK15108594.6A patent/HK1207970A1/xx unknown
-
2017
- 2017-05-15 US US15/595,407 patent/US9982037B2/en active Active
-
2018
- 2018-04-02 JP JP2018070701A patent/JP2018118991A/ja active Pending
- 2018-04-06 AU AU2018202468A patent/AU2018202468B2/en active Active
- 2018-04-23 US US15/959,430 patent/US10538578B2/en active Active
-
2019
- 2019-11-06 US US16/675,826 patent/US10947300B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
IL235237A0 (en) | 2014-12-31 |
US9982037B2 (en) | 2018-05-29 |
WO2013169377A1 (en) | 2013-11-14 |
CL2014003052A1 (es) | 2015-06-26 |
KR102122618B1 (ko) | 2020-06-29 |
JP6431477B2 (ja) | 2018-12-05 |
AU2013260123A1 (en) | 2014-11-13 |
CN104507500A (zh) | 2015-04-08 |
EP2846833A1 (en) | 2015-03-18 |
EP2846833A4 (en) | 2016-01-06 |
SG10201807059QA (en) | 2018-09-27 |
EP3492101A3 (en) | 2019-10-23 |
US20130302348A1 (en) | 2013-11-14 |
MX2014013678A (es) | 2015-02-04 |
US10538578B2 (en) | 2020-01-21 |
US20200123234A1 (en) | 2020-04-23 |
KR20150008180A (ko) | 2015-01-21 |
AU2018202468B2 (en) | 2020-04-16 |
EP3492101A2 (en) | 2019-06-05 |
US20170306003A1 (en) | 2017-10-26 |
HK1207970A1 (en) | 2016-02-19 |
US9683030B2 (en) | 2017-06-20 |
US20190062407A1 (en) | 2019-02-28 |
CA2871160A1 (en) | 2013-11-14 |
CA2871160C (en) | 2023-03-14 |
JP2015517492A (ja) | 2015-06-22 |
JP2018118991A (ja) | 2018-08-02 |
SG11201406769RA (en) | 2014-11-27 |
CN109265541A (zh) | 2019-01-25 |
AU2018202468A1 (en) | 2018-04-26 |
US10947300B2 (en) | 2021-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014027991A2 (pt) | agentes para neutralização de influenza | |
CY1124771T1 (el) | Αντισωματα εναντι-σορτιλiνης και μεθοδοι χρησης αυτων | |
PH12015502553A1 (en) | Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof | |
CY1119445T1 (el) | Αντισωματα εναντι του ανθρωπινου gdf8 | |
CL2018000108A1 (es) | Moléculas de anticuerpo que se unen a cd22 | |
CY1120398T1 (el) | Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη | |
BR112014009866A2 (pt) | formulações de anticorpos e métodos | |
EA032929B1 (ru) | Нейтрализующее вирус иммунодефицита человека антитело и способы его применения | |
IN2014CN00953A (pt) | ||
BR112018014615A2 (pt) | composições de anticorpo para ror1 e métodos relacionados | |
BR112013020500A2 (pt) | anticorpo isolado, recombinante ou purificado | |
EA201791086A1 (ru) | Человеческие антитела против гемагглютинина вируса гриппа | |
EA201791485A1 (ru) | Анти-cd47-антитела и их применения | |
UY37336A (es) | Anticuerpos anti-virus del zika y métodos de uso | |
BR112016005816A2 (pt) | Combinação de anticorpos anti-lag-3 e anticorpos anti-pd-1 para tratar tumores | |
EA201690167A1 (ru) | Гуманизованные или химерные антитела к cd3 | |
BR112017008945A2 (pt) | Anticorpos anti-cs1 e conjugados fármaco- anticorpo | |
WO2012021786A3 (en) | Anti-hemagglutinin antibody compositions and methods of use thereof | |
BR112014021251A2 (pt) | anticorpos humanos para toxinas de clostridium difficile | |
UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
PE20161032A1 (es) | Anticuerpos anti-tau(ps422) humanizados y metodos de utilizacion | |
EA201591973A1 (ru) | Антитела человека, связывающиеся с g-белком rsv | |
WO2013020074A3 (en) | A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin | |
BR112017022255A2 (pt) | anticorpo humanizado ou humano isolado, molécula de ácido nucleico isolada, vetor, célula hospedeira, método para produzir um anticorpo, e composição farmacêutica | |
EA201400447A1 (ru) | АНТИТЕЛА К CD1d |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |